Kleerekooper. energetic MS. However, advantages of carrying on the medication until pregnancy ought to be well balanced against the uncertainties in postnatal final results. The humanized monoclonal -4 integrin antibody natalizumab (NTZ) (Biogen Inc., Cambridge, MA) successfully reduces relapse price and disability development in sufferers with relapsing-remitting MS (RRMS).1,2 Sufferers starting NTZ will probably consider […]